These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26446740)

  • 1. [HIV treatment by ARV in resource-poor francophone countries].
    Lepère P; Milleliri JM
    Med Sante Trop; 2015; 25(3):237-44. PubMed ID: 26446740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges.
    Katabira ET; Oelrichs RB
    AIDS; 2007 Jul; 21 Suppl 4():S5-10. PubMed ID: 17620753
    [No Abstract]   [Full Text] [Related]  

  • 3. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings.
    Garnett GP; Bartley L; Grassly NC; Anderson RM
    Nat Med; 2002 Jul; 8(7):651-4. PubMed ID: 12091892
    [No Abstract]   [Full Text] [Related]  

  • 5. Community-based approaches to HIV treatment in resource-poor settings.
    Farmer P; Léandre F; Mukherjee JS; Claude M; Nevil P; Smith-Fawzi MC; Koenig SP; Castro A; Becerra MC; Sachs J; Attaran A; Kim JY
    Lancet; 2001 Aug; 358(9279):404-9. PubMed ID: 11502340
    [No Abstract]   [Full Text] [Related]  

  • 6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory monitoring of HIV/AIDS in a resource-poor setting.
    Glencross DK; Mendelow BV; Stevens WS
    S Afr Med J; 2003 Apr; 93(4):262-3. PubMed ID: 12806710
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral therapy where resources are limited.
    Reynolds SJ; Bartlett JG; Quinn TC; Beyrer C; Bollinger RC
    N Engl J Med; 2003 May; 348(18):1806-9. PubMed ID: 12724489
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative response: ranking country responses to HIV and AIDS.
    Desmond C; Lieberman E; Alban A; Ekström AM
    Health Hum Rights; 2008; 10(2):105-19. PubMed ID: 20845862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
    Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J
    Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
    Assefa Y; Kloos H
    Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of children with Kaposi sarcoma in resource limited settings.
    Molyneux E; Davidson A; Orem J; Hesseling P; Balagadde-Kambugu J; Githanga J; Israels T
    Pediatr Blood Cancer; 2013 Apr; 60(4):538-42. PubMed ID: 23255282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?
    Colebunders R; Florence E; Lynen L; Bouckenooghe A
    Int J STD AIDS; 2003 Jan; 14(1):1-5. PubMed ID: 12590784
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 care in resource-poor settings: a view from Haiti.
    Mukherjee JS
    Lancet; 2003 Sep; 362(9388):994-5. PubMed ID: 14513853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Potential use of total lymphocyte count and CD8 T cell immune activation markers in monitoring HIV/AIDS progression and antiretroviral therapy in resource-limited settings].
    Li TS; Xie J
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):641-3. PubMed ID: 20979777
    [No Abstract]   [Full Text] [Related]  

  • 18. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.
    Colebunders R; Moses KR; Laurence J; Shihab HM; Semitala F; Lutwama F; Bakeera-Kitaka S; Lynen L; Spacek L; Reynolds SJ; Quinn TC; Viner B; Mayanja-Kizza H
    Lancet Infect Dis; 2006 Jan; 6(1):53-9. PubMed ID: 16377535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV, breast feeding and antiretroviral agents].
    Engebretsen IM; Tylleskär T
    Tidsskr Nor Laegeforen; 2010 Mar; 130(5):520-2. PubMed ID: 20224625
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral treatment in resource-poor settings: clinical research priorities.
    Rabkin M; El-Sadr W; Katzenstein DA; Mukherjee J; Masur H; Mugyenyi P; Munderi P; Darbyshire J
    Lancet; 2002 Nov; 360(9344):1503-5. PubMed ID: 12433534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.